Kevin Hunt

Dr. Hunt serves as our Chief Scientific Officer. Prior to joining Vanqua Bio, Kevin was Executive Director of Drug Discovery for Edgewise Therapeutics where he oversaw internal and external medicinal chemistry, preclinical CMC, ADME, and non-GLP toxicology. Kevin has discovered multiple clinical candidates for life threatening diseases and has published over fifty patents and publications. Previously, he led target validation and preclinical development activities as a faculty member in the Center for Alzheimer’s and Neurodegenerative Diseases at The University of Texas Southwestern Medical Center. Before UTSW, Kevin was Site Head of the Calico Life Science outpost in Dallas where he focused on novel treatments for Parkinson’s disease and evaluated potential new targets. Kevin began his career at Array BioPharma in Boulder leading teams that discovered multiple clinical and pre-clinical candidates for allergic diseases, oncology, and neurogenerative disorders. Kevin was a Presidential Honors Scholar and Varsity Cross Country Runner at Tarleton State University where he received his B.S. in Chemistry. He earned a Ph.D. in Organic Chemistry from Indiana University and was a George E. Hewitt Foundation for Medical Postdoctoral Research Fellow at The Scripps Research Center.